dr. melnick discusses the epigenetic basis of b-cell lymphomas
Published 11 years ago • 187 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:54
dr. melnick on epigenetic diversity and clinical outcomes in dlbcl
-
2:27
dr. melnick discusses the future of chemotherapy in lymphomas
-
3:38
dr. melnick on epigenetic biomarkers in types of lymphoma
-
22:33
epigenetic therapy for lymphoma: from the laboratory to the clinic
-
7:18
precision epigenetic therapy for b-cell lymphoma
-
2:04
dr. melnick on targeting ezh2 in dlbcl
-
1:09
dr. melnick on emerging targets in lymphoma
-
2:14
dr. melnick on ezh2 as a potential target in diffuse large b cell lymphoma
-
3:19
dr. ari m. melnick on biomarkers in lymphoma
-
1:28
dr. ari melnick on malt1 as a potential target in dlbcl
-
2:02
dr. melnick on emerging therapies for the treatment of mantle cell lymphoma
-
9:20
the role of epigenetic modulators in the pathogenesis of lymphomas
-
3:59
the critical role of sirt3 in lymphomagenesis
-
2:06
dr. melnick on somatic mutations and the flt-3 biomarker in aml
-
21:46
current understanding of a genetic/epigenetic basis of classic mpns
-
5:24
translating epigenetic therapy to the clinic: rational combinations
-
2:01
epigenetic regulation of immune microenvironment interactions in lymphoma
-
4:10
the good, the bad and the epigenetics
-
1:42
precision medicine for b-cell lymphomas